https://www.marketscreener.com/quote/stock/GSK-PLC-9590199/news/GSK-Phase-3-Trial-for-Jemperli-Endometrial-Cancer-Treatment-Met-Primary-Endpoint-42458889/?utm_source=telegram&utm_medium=social&utm_campaign=share